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Cell-matrix interactionsBiomaterials combining biochemical and biophysical cues to establish close-to-extracellular matrix
(ECM) models have been explored for cell expansion and differentiation purposes. Multivariate arrays
are used as material-saving and rapid-to-analyze platforms, which enable selecting hit-spotted formula-
tions targeting specific cellular responses. However, these systems often lack the ability to emulate
dynamic mechanical aspects that occur in specific biological milieus and affect physiological phenomena
including stem cells differentiation, tumor progression, or matrix modulation. We report a tailor-made
strategy to address the combined effect of flow and biochemical composition of three-dimensional
(3D) biomaterials on cellular response. We suggest a simple-to-implement device comprising (i) a perfo-
rated platform accommodating miniaturized 3D biomaterials and (ii) a bioreactor that enables the incor-
poration of the biomaterial-containing array into a disposable perfusion chamber. The system was
upscaled to parallelizable setups, increasing the number of analyzed platforms per independent experi-
ment. As a proof-of-concept, porous chitosan scaffolds with 1 mm diameter were functionalized with
combinations of 5 ECM and cell-cell contact-mediating proteins, relevant for bone and dental regenera-
tion, corresponding to 32 protein combinatorial formulations. Mesenchymal stem cells adhesion and pro-
duction of an early osteogenic marker were assessed on-chip on static and under-flow dynamic perfusion
conditions. Different hit-spotted biomaterial formulations were detected for the different flow regimes
using direct image analysis. Cell-binding proteins still poorly explored as biomaterials components –
amelogenin and E-cadherin – were here shown as relevant cell response modulators. Their combination
with ECM cell-binding proteins – fibronectin, vitronectin, and type 1 collagen – rendered specific bioma-
terial combinations with high cell adhesion and ALP production under flow. The developed versatile sys-
tem may be targeted at widespread tissue regeneration applications, and as a disease model/drug
screening platform.
Statement of Significance
A perfusion system that enables cell culture in arrays of three-dimensional biomaterials under dynamic
flow is reported. The effect of 31 cell-binding protein combinations in the adhesion and alkaline phos-
phatase (ALP) production of mesenchymal stem cells was assessed using a single bioreactor chamber.
Flow perfusion was not only assessed as a classical enhancer/accelerator of cell growth and early osteo-
genic differentiation. We hypothesized that flow may affect cell-protein interactions, and that key com-
ponents driving cell response may differ under static or dynamic regimes. Indeed, hit-spotted
formulations that elicited highest cell attachment and ALP production on static cell culture differed from
the ones detected for dynamic flow assays. The impacting role of poorly studied proteins as E-cadherin
and amelogenin as biomaterial components was highlighted.
 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
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The poor isolation of the role of individual factors and their
interplay on human tissues healing ability hinders the develop-
ment of simplified, yet relevant and effective, implantable tissue
engineering systems and in vitro testing devices [1]. Deconstructed
biophysical and structural elements can be used as a powerful
source to drive the bio-instructed potential of biomaterials [2].
To do so, the rational testing of compositional variates and their
synergic role with other native niche aspects (such as mechanical
stimuli) is necessary to successfully establish a solid bridge
between fundamental biology and the effective design of engi-
neered systems [3].
The extracellular matrix (ECM) is accepted as a cornerstone
aspect for the maintenance of tissues function and regeneration
capability. Since it is the three-dimensional (3D) matter that
embeds cells, it provides mechanical cues and physical/structural
support to tissues, is composed of molecules secreted by the tis-
sues’ own cells, and regulates several signaling pathways [4]. Such
phenomena involve cell-cell and cell-matrix adhesion mediation
proteins, which also have significant roles in the recruitment and
binding of growth factors that trigger signaling cascades com-
monly involved in cell differentiation signaling [5]. Different pro-
teins that compose the ECM are known to dictate specific cell
responses on their own. However, in physiological situations,
ECM proteins act as part of a coordinated system that comprises
other proteins and molecules [6]. Besides the challenging task of
understanding the biochemical diversity of the ECM, the use of
3D systems capable of resembling the native ECM architecture
and micromechanical environment is also of utmost importance
to achieve in vitro/in vivo correlating results [7–9] and to identify
critical aspects to increase the yield of in vitro approaches [10–13].
Mechanical factors have proven to be powerful adjuvants of
regeneration [14]. These stimuli naturally occur in human tissues,
and their application has been relevant for the development of cel-
lular in vitro-modulating strategies [15]. Bioreactors are a useful
tool due to their ability to maintain 3D ECM-mimetic constructs
under conditioning stress [16]. Perfusion bioreactors were reported
to enhance the homogeneous distribution of cells inside scaffolds
and to provide increasing fluid circulation inside biomaterials’
structure, enhancing the accessibility of oxygen and vital nutrients
to cells [17,18]. Operating conditions include the administration of
continuous or pulsatile flow to pose significant shear stress on cells
[19,20], or the promotion of effective medium perfusion with
neglectable mechanical stimulation [21]. Bancroft et al. [22]
described a seminal approach based on the use of a perfusion
bioreactor for the stimulation of stem cells seeded on 3D polymeric
scaffolds targeting bone regeneration. Healthy bone is known to
remodel as a response to mechanical stress [23], and studies focus-
ing on the role of perfusion on primary bone cells and stem cells
showed increased mineralized matrix deposition in a shear flow
dose-dependent manner [24–26].
High-throughput screening has enabled the characterization of
multivariate systems in a cost- and time-saving manner [27–32].
While several high-throughput screening platforms have been
applied to assess the osteogenic potential of biomaterials [31,33–
37], those and other in vitro and in vivo high-throughput screening
experiments have mostly been performed using platforms limited
to static setups [38,39]. Flow perfusion studies targeting tissue
engineering have mostly been limited to experiments using a
low number of biomaterials. Therefore, the modulatory effect of
dynamic flow on the response of cells cultured on chemically
diverse biomaterials is still poorly explored. Moreover, the effect
of dynamic perfusion on stem cells has often been addressed as
an ‘‘enhancing” and/or accelerating factor for cell proliferationand differentiation. We hypothesize that screening arrays of com-
binatorial biomaterials (tailored to present different cell-binding
domains) in the presence/absence of flow may enlighten the role
of mechanical stimulation as a modulating agent of cell-
biomaterials interactions.
Here, we report the screening of the effect of a library of 3D
biomaterials on BMSCs response in the presence or absence of
a flow perfusion flow. For that, a simple and affordable bioreactor
was designed. Miniaturized chitosan scaffolds were patterned on
a flexible perforated hollow platform, and each individual scaf-
fold was chemically modified with a 5-factor combinatorial pro-
tein system, comprising proteins associated with ameliorated cell
adhesion, proliferation and osteogenic differentiation. Three
native bone cell-binding ECM proteins with distinct roles – type
1 collagen (C), fibronectin (F), and vitronectin (V) – were selected.
Type 1 collagen is the most common protein both in adult and
developing bone [6]. Fibronectin is also a native component of
bone, and its cell-binding RGD is one of the most widely studied
cell-binding domains [40,41]. Although these two bone ECM pro-
teins have induced successful MSCs osteogenic differentiation,
their action is mostly regulated by tailored biophysical parame-
ters such as stiffness [42]. Vitronectin has been much less
explored in the realm of biomaterials. Its role in bone has been
classically correlated with osteoclasts’ function, and more
recently with osteoblasts function [43]. Previously, its combina-
tion with collagen has been associated with the osteogenic differ-
entiation [44]. Despite not being natively present in bone,
amelogenin (A) was capable of inducing MSCs osteogenic differ-
entiation in biomaterial-free in vitro experiments [45]. However,
its incorporation in biomaterials targeting bone regeneration
has not been directly explored. Finally, E-cadherin (E) was
selected for its reported role on improved cellular proliferation
of MSCs [46], and we hypothesized that its addition to the sys-
tem could be effective on promoting the simultaneous BMSCs
proliferation during osteogenic differentiation. BMSCs response
under (i) static conditions and (ii) continuous flow perfusion con-
ditions was assessed concerning cell adhesion and production of
the osteogenic early marker alkaline phosphatase (ALP). The tech-
nology reported here allowed disclosing combined effects of
dynamic perfusion and multivariate biomaterial compositions
on stem cells response.2. Materials and methods
2.1. Preparation of hollow arrayed platform
A solution of polydimethylsiloxane (PDMS, Elastomer Kit, Dow
Corning) in a ratio of 5:1 (PDMS:curing agent) was prepared and
degassed under vacuum for 1 h. A volume of 3 mL was pipetted
onto a mold, schematically represented on Fig. 1A, B. The molds
comprised a perforated Teflon base and hollows covered with
stainless steel spikes (purchased in a local commerce) with 1 mm
circular diameter. The molds containing PDMS solution were again
degassed under vacuum for 1 h and cured in an oven (Oven/Labo-
ratory dryer, Ecocell 55 Frilabo) at 70 C for 1 h. The solid PDMS
perforated platform was removed from the mold and showed
approximately 2 mm height and 4  4 cm2 area. The hollows had
1 mm circular diameter.2.2. Preparation of microarrayed miniaturized 3D chitosan scaffolds
A 0.9% chitosan (medium molecular weight, deacetylation
degree 75%, Sigma-Aldrich) solution was prepared using glacial
acetic acid (LabChem) at 1% (w/v). A volume of 3 lL was pipetted
Fig. 1. Method for the preparation of the hollowed array platform used to pattern 3D biomaterials: (A), (B) dispensing of PDMS and curing agent mixture (liquid) in a ‘‘bed of
nails” structure with 1 mm diameter nails; (C) exposure of the PDMS structure to temperature for solidification and removal of a hollow patterned PDMS structure
afterwards. Top view representations are presented below the side view schematics. Patterning of miniaturized 3D chitosan scaffolds arrays on PDMS hollow platforms and
respective use for protein mixtures deposition and cell culture studies: (D) deposition of microliter volumes of a chitosan solution on the hollowed spots, followed by freeze-
drying, leading the formation of porous structures (SEM images); (E) pipetting of distinct protein combinations of human fibronectin (FN), vitronectin (VN), type I collagen
(Col), amelogenin (AML) and E-cadherin (E-cadh) in each spot of the array; the proteins were bound to chitosan scaffolds by the EDS/NHS chemistry; (F) deposition of a
suspension of BMSCs on each protein-modified and control chitosan scaffolds for further microscopic assessment of cell response.
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solution, the platforms were suspended using two micropipette
tips in each side during the pipetting step. The platform containing
chitosan solution in the wells was frozen at 20 C for 4 h, and
then freeze-dried (LyoQuest Plus Eco,VWR) overnight. The scaf-
folds were then neutralized by adding droplets of 1 M sodium
hydroxide (NaOH, Eka, AkzoNobel) solution prepared in 70% (v/v)
ethanol (Valente & Ribeiro). After 10 min neutralization, the whole
platforms were washed with distilled water for 30 min (three
cycles of 10 min). The samples were frozen again at 20 C for
4 h and freeze-dried overnight. The platforms were sterilized prior
to cell culture by exposure to UV irradiation for 30 min in each side
of the platform (Laminar Flow Cabinet S@femate Eco 1.2 m,
EuroClone).
2.3. Preparation of protein solutions
Five human proteins were used in this study: fibronectin
(F, Sigma Aldrich), vitronectin (V, Sigma Aldrich), E-cadherin
(E, Advanced BioMatrix), collagen type I (C, Sigma Aldrich) and
amelogenin (A, AMELX, ab139212, Abcam). Solutions of the 5 pro-
teins were prepared by dissolution of the stock solution in a phos-
phate buffered saline solution (PBS, ThermoScientific). The protein
solutions were all diluted to the same final concentration,
0.05 mg/mL, in a total protein amount in a range used by others
for protein surface immobilization and bone tissue regeneration
studies [37,47]. Protein solutions used for immobilization onchitosan scaffolds were prepared with equal proportions of each
protein. The final protein solutions had the same final mass of each
individual protein.2.4. Protein immobilization onto miniaturized chitosan 3D scaffolds
Solutions of N-hydroxysuccinimide (NHS, Sigma Aldrich) and
N-(3-Dimethylaminopropyl)-N0-ethylcarbodiimide hydrochloride
(EDC, Fluka) were added to the protein solutions, in a proportion
of 1:1:2, (v/v) EDC:NHS:protein solution, accordingly to a previ-
ously reported method [47]. EDC and NHS concentrations in the
protein solutions were 2 mM and 5 mM, respectively. A volume
of 1 lL of each protein mixture was pipetted onto single scaffolds
and reacted for one hour at room temperature. Single platforms
were then washed in 100 mL of sterile PBS (changed three times).2.5. Morphological analysis of miniaturized 3D scaffolds arrays:
scanning electron microscopy
An analytical field emission scanning electron microscope
(SEM) SU-70 (Hitachi, Japan), operated at 15 kV, was used to study
the morphology of the patterned scaffolds. All samples were fixed
by mutual conductive adhesive tape. Before analysis, all samples
were coated with a thin layer of gold/palladium using a sputter
coater.
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Bone marrow-derived mesenchymal stem cells (BMSCs) were
purchased from LGC Standards, ATCC. The undifferentiated cells
were cultured and expanded under basal condition, using Mini-
mum Essential Alpha Medium (alpha-MEM, Sigma, USA), supple-
mented with 10% (v/v) fetal bovine serum (ThermoFisher
Scientific) and 1% (v/v) penicillin-streptomycin (ThermoFisher
Scientific).
2.7. Cell seeding
A suspension of 5000 BMSCs cells/lL was pipetted at a volume
of 1 lL onto the scaffolds with previously immobilized proteins.
Cells were left to attach to the material for 30 min at 37 C. After
this seeding step, the platforms were washed once with PBS and
incubated (CO2 Incubator, Model C170, Binder) at 37 C, 5% CO2
with 5 mL of cell culture medium using non-adherent cell culture
plates. Cells were used on passages of P2 to P6, and cell culture
medium was exchanged every 2 days.
2.8. Bioreactor assembly
A perfusion bioreactor was assembled to withstand two parallel
replicates of each individual setup. The number of parallel repli-
cates depends solely on the available channels of the peristaltic
pump used to perfuse the medium. Each individual set of the biore-
actor comprised: (i) one chamber with cell culture medium, cap-
able of holding the hollow PDMS platform containing 3D
scaffolds arrays and respective adhered cells, (ii) tubes (Tygon ST
R3607, Ismatec, 3.17 mm outer diameter) for medium transporta-
tion, (iii) one individual reservoir of cell culture medium (Schott,
250 mL), and (iv) one peristaltic pump (REGLO digital MS-2/6-
160). The tubes were connected to the cell culture medium reser-
voir through a commercially available screw cap (Screw cap HPLC,
GL 45, 4 ports, Duran) with four ports (3.0 mm diameter). The
inlet tube, that drove medium flux to the bioreactor chamber,
was inserted inside the cell culture medium; the outlet tube, which
recirculated the cell culture medium back to the reservoir, was left
about 1 cm above the cell culture medium meniscus. The tubes
connecting the medium reservoir and the bioreactor chamber wereFig. 2. (A) Schematic representation of the developed bioreactor. One individual unit of
one peristaltic pump, and a tailored chamber that withstands the arrayed hollowed pla
representation of the bioreactor chamber used to apply a continuous unidirectional flow
reservoirs and independent chambers containing two biomaterial arrays. The number o
peristaltic pump. (D) The arrays were cultured on static and under flow conditions for 1 d
for their content of live cells and alkaline phosphatase (ALP).coupled in the channels of a peristaltic pump. Gas exchange in the
cell culture medium was promoted through the assembly of two
0.2 lm sterile cellulose acetate syringe filters (30 mm diameter;
WhatmannTM/GE Healthcare) in the two remaining entries of the
reservoir cap. The bioreactor chamber was composed of two sterile
20 mL polypropylene syringes (VWR) without the respective pis-
tons. Tubes were connected to the outlet of the syringes, and both
syringes were attached together containing the perforated arrayed
platform in between both syringes. The chamber was sealed using
sterile Parafilm and insulation tape on outer layers. All tube-tube
and syringe-tube junctions were also sealed with Parafilm and
insulation tape, which successfully impaired any fluid loss. The
schematic representation of the bioreactor assembly is depicted
in Fig. 2A, B. A picture of the bioreactor containing two parallel set-
ups (two bioreactor chambers fed by two individual cell culture
medium containers) assembled to the same peristaltic pump can
be seen in Fig. 2C.2.9. Numerical simulations of the bioreactor
The numerical studies were performed in OpenFOAM computa-
tional library and, as described in the main text, comprised two
phases: (i) study of a representative region of the 3D scaffold; (ii)
study of the flow on the whole bioreactor chamber. On the initial
phase, the solver employed in the calculations was simpleFoam,
which is appropriate for the calculation of steady state Generalized
Newtonian incompressible fluid flows. The geometries and compu-
tational meshes required for the numerical studies were generated
in Blender and cfMesh, respectively. The relation between the pres-
sure drop and velocity, computed for the representative 3D scaf-
fold region, plotted in Fig. 3B, was fitted to a Darcy porous model
using Microsoft Excel. For the calculations done on the global
bioreactor, during the second phase of the numerical studies, the
solver simplePorousFoam was employed, to allow the definitions
of porous regions at the scaffolds, using the Darcy model parame-
ters obtained on the initial phase. To post-process the results a new
utility was created in OpenFOAM to calculate the flow in each of
the scaffolds, whose IDs are provided in Fig. S3 (Supporting Infor-
mation). For that purpose, a face set was created at the cross sec-
tion of each scaffold using the setSet utility, and the new routinethe bioreactor comprises one medium reservoir, tubing for medium transportation,
tform (image (a)) containing 3D porous chitosan scaffolds (image (b)). (B) Detailed
of 0.68 mL/min. (C) Image of a parallel setup of bioreactor containing two medium
f parallel setups is mainly dependent on the number of available channels in the
ay and 5 days, and biomaterials were later analyzed using image-based techniques
Fig. 3. Flow simulations on a representative region of the 3D scaffolds and on the bioreactor chamber. A) Geometry (a) and computational mesh (b) of the representative 3D
scaffold region used on the numerical studies. B) Numerical results for the evolution of pressure drop and average shear stress as function of the flow rate, for the
representative 3D porous scaffold region. C) Shear stress distribution at the pores surface, for the flow rate of 0.682 mL/min. D) Effect of the flow rate on the relative difference
between the maximum and minimum flow rates obtained for each porous scaffold. E) Geometry (a) and computational mesh (b) employed for the full system (bioreactor
chamber) simulation.
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desired individual flow rate in each individual scaffold.
2.10. Dynamic and static (control) on-chip cell culture
The PDMS platforms containing an array of scaffolds seeded
cells were placed in the bioreactor chamber using sterile tweezers.
BMSCs were cultured in the platforms for 1 day, under static con-
ditions, prior to the assembly in the bioreactor. For static control
experiments, cell culture continued under static conditions inside
suspension Petri dishes, with 8 mL supplemented cell culture med-
ium. On dynamic culture, after the complete bioreactor sealing, the
bioreactor reservoirs and chambers were placed on an incubator at
37 C and 5% CO2. The bioreactor chambers were placed in a hori-
zontal position. The peristaltic pump was set with a flow of0.68 mL/min. The experiments were then carried out for 1 day
and 5 days of incubation. To remove the scaffold arrays from the
bioreactor, the parafilm and insulating tape shell used to seal
the syringes chamber was cut with a sterile scalpel inside a laminar
flow chamber. The platform was then carefully removed using
sterile tweezers. All scaffold arrays were washed with sterile PBS,
and immediately analyzed for cell viability.
2.10.1. Viability analysis
The scaffold arrays retrieved from static and dynamic cell cul-
ture were immersed in 2 mL of sterile PBS containing 4 lg of cal-
cein AM (Thermo Fisher Scientific) and 2 lg of propidium iodide
(PI, Thermo Fisher Scientific) in the incubator at 37 C, 5% CO2,
for 30 min. The platforms were then analyzed using a fluorescence
microscope (Axio Imager M2, Zeiss) with both Calcein/propidium
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acquired in each individual spot of the platform. Automated data
acquisition was performed with a Zeiss M2 microscope (Zeiss)
equipped with a controlled xyz table. For image analysis, the area
of the scaffolds was selected, and the image was later treated as a
‘‘region of interest” (ROI), in which green fluorescence intensity
was directly measured using the ZEN software (Zeiss). After the
analysis, the chips were fixed with formalin at 4% (Sigma), at
4 C, for one day. The semi-quantitative results for calcein AM sig-
nal quantification were calculated by dividing the detected inten-
sity in each formulation by the one detected in the protein-free
control in each individual time point. Higher ratios represented
conditions with higher detected calcein signal.
2.10.2. ALP quantification analysis
After fixation with formalin, the platforms were washed twice
with distilled water for 30 min, and then immersed in an ALP sub-
strate solution (1-StepTM NBT/BCIP Substrate Solution, ThermoSci-
entific). The reaction took place at 37 C, for 4 h. The ALP present
in the array was stained in purple. However, a method based on
fluorescence analysis was developed to perform rapid and easy
analyses of ALP presence in each individual scaffold. Whole plat-
form images were acquired automatically using a fluorescence
microscope equipped with a xyz-controlled table, at an exposure
time of 60 ms, using the Calcein filter. The chitosan scaffolds show
autofluorescence. The places stained for ALP show a non-
fluorescent signal, and black spots can be observed in the exact
places where ALP is visibly stained. The relative semi-
quantitative assessment of ALP per scaffold was performed by
increasing the fluorescent signal of the all images equally, and by
quantifying the fluorescent signal in each individual scaffold. Scaf-
folds with lower detected fluorescence were the ones with higher
amounts of ALP. The semi-quantitative results for ALP quantifica-
tion were calculated by dividing the detected intensity in each for-
mulation by the one detected in the protein-free control. Lower
ratios represented conditions with higher amount of detected ALP.
2.11. Statistical analysis
All data was treated and plotted using GraphPad Prism 6 Soft-
ware. Multivariate factorial ANOVA analysis and calculation of
compositional effects was performed using the Design-Expert 10
Software using Response Surface Methodology. A five-component
multifactorial approach was designed, in which each protein was
labelled in two different levels: existent (level 1) or inexistent
(level 0). Statistical significance was considered for factors with
p < 0.05. Hierarchical clustering of data was performed using the
PAST 3.19 Software. Box plot charts showing medians, minimum
and maximum measured values are depicted in Supporting Infor-
mation – Figs. S4 and S5.3. Results
3.1. Design of a miniaturized perforated platform and patterning of
miniaturized 3D environments
Using the device based on hollows filled with biomaterials
depicted in Fig. 1A–C, hollows’ height, diameter, sectional shape
and interunit distance were amenable to be easily tailored to
achieve scaffolds with versatile sizes, section shapes and spatial
distribution by altering the mold used to cast PDMS. The possible
control over PDMS crosslinking extent, through the application of
tailored curing temperature, time and proportion of curing agent,
may enable the production of platforms with distinct stiffnesses,
amenable to be used in complex multi-stimuli experiments. Theeasy access to miniaturized porous chitosan 3D scaffolds enabled
the modification of individual biomaterials with distinct protein-
content formulations (Fig. 1E, F). Here, human proteins including
fibronectin, vitronectin and type-I collagen are presented to cells
as adhesive proteins present in native human tissues’ ECMs, cap-
able of mediating cell-matrix interactions through different mem-
brane integrins [48]. Amelogenin is added to the system as a cell-
binding enamel protein strongly associated with the osteogenic
commitment of MSCs [45] and improved bone regeneration [49].
E-cadherin is used as a simulator of cell-cell contact, as previously
studied on biomaterials’ surfaces [50].
3.2. Design of a perfusion bioreactor compatible with the high-
throughput study of protein-BMSCs interactions
The bioreactor described here was assembled with common,
affordable and disposable labware (Fig. 2A–C). The independency
from tailor-made pieces facilitates the assembly of this device in
any laboratory. The bioreactor chamber was easily closed and iso-
lated using layers of sterile parafilm and insulation tape. Here, the
use of micromachined chamber, O-rings and other commonly used
accessories was avoided, decreasing costs and handling steps that
may culminate in microbial contaminations of the whole setup.
The effect of 31 distinct protein formulations on BMSCs cell
adhesion and early osteogenic differentiation on static conditions,
or under perfusion flow (0.68 mL/min; Fig. 2D) was studied using
the high-throughput perfusion bioreactor. Since scaffolds’ architec-
ture affects the effective shear stress posed to cells, we performed a
computational flow simulation study that enabled predicting the
range of shear stress values through the bioreactor, and specifically
in the 3D porous regions of the miniaturized scaffolds. The flow
simulations were performed to calculate the main flow variables,
including the shear stress, at the PDMS platform and throughout
the bioreactor chamber. The numerical study was performed using
the OpenFOAM computational library [51], and was divided in two
phases: (i) analysis of a representative porous scaffold region and
(ii) the assessment of the flow on the whole bioreactor chamber,
including the perforated PDMS platform containing 3D porous
scaffolds, computed in step (i). On the first phase, the flow was
modelled in a representative region of the porous scaffolds – rep-
resented by a cube with 250 mm side –, whose geometry was ran-
domly generated, with a porosity of circa 80% and pore diameter of
60 mm (Fig. 3). Both geometry and computational mesh employed
at this stage are illustrated in Fig. 3A. The direct numerical simula-
tion of the flow was performed for a range of representative flow-
rates, up to around 40 mL/min, to obtain the relation between
velocity and pressure drop for the representative porous scaffolds
region, as shown in Fig. 3B. The collected data was employed to
devise the parameters of the Darcy model characteristic for the
scaffolds’ porous regions. Results illustrated in Fig. S1 (Supporting
Information) show the tortuous nature of the flow while passing
though the porous scaffold region.
The effect of the flow rate on the shear stress induced at the
pores’ surface was also predicted by the numerical code, as illus-
trated in Fig. 3C, for the flow rate of 0.682 mL/min, which was
applied herein in the characterization of cell-biomaterials interac-
tions. Based on obtained results, the walls of the porous scaffolds
were subjected to a shear stresses in the range of 10–90 mPa.
Based on this result, each individual scaffold of the perforated plat-
form inserted in the bioreactor chamber could be stimulated with
shear stresses in the range of the ones reported in previous biore-
actor setups comprising 3D biomaterials for cell culture [52–54].
The numerical studies performed on the second phase had the
main purpose of verifying the effect of the flow rate on the flow
distribution on each individual porous scaffold region. For that,
those regions were identified, as shown in Fig. S2 (Supporting
228 D. Lopes et al. / Acta Biomaterialia 96 (2019) 222–236Information), and the flow rate in each one was calculated for all
the numerical runs. Consequently, the numerical analysis con-
sisted on the study of the full bioreactor system using the porous
scaffold model obtained in the previous phase, which was
employed on the perforated regions. For that, those regions were
identified, as shown in Fig. S2 (Supporting Information), and the
flow rate in each one was calculated for all the numerical runs per-
formed. Fig. 3D depicts the relative difference of the maximum and
minimum flow rates obtained among all the regions, proving that
up to 1 mL/min flow rates the differences in the flow observed in
each individual scaffold are neglectable. A trend to unbalance the
flow distribution in different scaffolds of the bioreactor could only
be detected above that flowrate. Importantly, even for the highest
flow rate considered  40 mL/min – the predicted difference
between the maximum and minimum flows is below 0.14%, indi-
cating a still acceptable homogeneity of the flow distribution
throughout all scaffolds in the bioreactor. Notice, that the restric-
tive effect of the porous regions favours the flow distribution
uniformity.
Fig. 3E shows both the system geometry and the mesh
employed on the numerical runs. Figs. S2 and S3 (Supporting Infor-
mation) illustrate, respectively, the pressure distribution and
respective individual cell region IDs employed to monitor the flow
distribution; and the streamlines that were computed for the
reference flow rate employed on the experimental studies:
0.68 mL/min. From the pressure drop distribution (Fig. S2,
Supporting Information), it was observed that the scaffold region
is responsible for the most pressure drop obtained on the compu-
tational domain, a direct outcome of the flow restriction promoted
by the porous regions.
3.3. In vitro characterization of BMSCs response
The behavior of BMSCs cultured on the 3D scaffold arrays was
characterized by image analysis. The calcein signal intensity
detected in each individual spot was used as a semi-quantitative
indicator of cell number in each biomaterial. ALP is an enzyme
which increased activity has been widely reported as an indication
of early osteogenic differentiation of MSCs [55]. The loss of autoflu-
orescence from chitosan scaffolds, resulting from the reacted ALPFig. 4. Fluorescence microscopy images of live BMSCs (staining with calcein; green) on b
free) conditions, after (A) 1 day and (B) 5 days of cell culture. Each condition is represente
to colour in this figure legend, the reader is referred to the web version of this article.)product (without any fluorescence emission), was used as a
semi-quantitative method to detect the presence of this protein
in single spots. All results were normalized to the protein-free con-
trol, and they allowed to infer about the role of additive proteins to
the chitosan scaffolds, as well as synergic effects between protein
formulations and static/dynamic flow regimes.
The ratio between calcein signal intensity quantified in the
protein-free spot (here, ‘‘control”) and the calcein signal intensity
detected on the protein-containing formulations was calculated
for all independent platform experiments. Fig. 4 depicts images
of on-chip cellular calcein staining on biomaterial formulations
that led to highest detection values and low-variability calcein sig-
nals after 1 day (panel A) and 5 days (panel B) of cell culture. Nor-
malized mean average values obtained for calcein ratios for all
studied conditions are presented in Fig. 5A, as well as a cluster
charts grouping these results (Fig. 5B). The original calculated
ratios are presented as box plot charts (presenting median, mini-
mum and maximum measured values) in Fig. S4, Supporting
Information.
For 1 day cell culture under static environment, the conditions
EC, VECA and FECA showed high and consistent (p < 0.1; compar-
ison with protein-free control) calcein intensities (Fig. 5A). Other
conditions presenting high mean average values for calcein ratios
were E, VE, VA, FC, VEC and FCA. One of the most recurrent compo-
nents of these mixtures is the cell-adhesive protein type-I collagen,
which is present in the human native bone ECM. The presence of
collagen in the chitosan scaffolds by itself, however, was not
enough to trigger a higher cell number in the scaffolds as compared
to the protein-free control. Another protein with high predomi-
nance in the formulations that elicited higher calcein signal was
E-cadherin. Here, the modification of chitosan scaffolds with E-
cadherin alone was enough for high calcein signal detection. When
allied to cell adhesive ECM proteins – fibronectin, collagen and vit-
ronectin –, E-cadherin showed improved cell adhesion capacity.
The mixture of E-cadherin with ECM adhesive proteins was effec-
tive on specific binary, ternary and quaternary combinations, indi-
cating that the proteins kept their function even in lower
proportion in the formulations. In general, initial BMSCs adhesion
to chitosan scaffolds seems to be enhanced in combinatorial pro-
tein combinations, instead of single protein formulations. ECMiomaterial formulations rendering highest calcein signal ratios and control (protein-
d with 3 images from independent experiments. (For interpretation of the references
Fig. 5. (A) Heatmap representation of cell viability for all scaffolds cultured under static and dynamic conditions, for 1 day and 5 days of cell culture. The represented values
are normalized (0: minimum to 1: maximum) from the raw mean average values of calcein ratios (normalized by the internal independent experiment control: protein-free
scaffold) based on an automated analysis of image fluorescence. Values obtained for three independent experiments are presented, as well as the calculated mean average
(avg; n = 3 to 9). Conditions with statistically significantly higher detection of calcein (p < 0.1; t-test against control) are indicated with the ‘‘*” symbol. The respective median
and minimum/maximum values are depicted in Fig. S4 in the Supporting Information. Dentograms with the hierarchical clustering of the average cell viability values for (B)
1 day and (C) 5 days of cell culture for static and dynamic conditions.
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genin in certain formulations, seem to have a synergic effect on
this phenomenon. After 5 days of static culture, the hit-spotted for-
mulations driving increased and low-variation calcein signal were
FEA and VEA. Moreover, EA, VC, FEC, FEA, FVE, ECA, VECA and FVEA
also showed the highest mean average ratios. For this time point,
combinations of cell-matrix adhesion proteins (here, fibronectin
and/or vitronectin), cell-cell contact proteins (here, E-cadherin)
and enamel amelogenin promoted the highest number of adherent
cells.
For 1 day dynamic culture conditions, highest and least variable
calcein signals were detected on FVA, ECA and FECA scaffolds. The
interaction between ECM adhesive proteins (fibronectin, type I col-
lagen) along with E-cadherin and amelogenin seem to dictate
higher cell adhesion to materials. For 5 days of cell culture under
dynamic flow stimulation, VEA, FVEA and VECA presented consis-
tently increased high calcein ratios, corroborating previous results
indicating the important role of the interactions between adhesive
proteins, E-cadherin and amelogenin as constituents of hit-spotted
conditions promoting enhanced cell number on biomaterials.
Despite consistent patterns indicating the combined presence
of ECM integrin-binding proteins with E-cadherin and amelogenin
as driving forces of effective cell adhesion on biomaterials, the
presence of these protein combinations on several 3D biomaterials
compositions was not enough to drive higher cell adhesion to the
substrates, suggesting that cells respond to specific protein-
protein combinatorial effects, instead of single composition-
driven effects. Indeed, effect analysis using multivariate surface
response methods indicated few significant factors as statistically
relevant for cell number determination in each biomaterial. These
included for 1 day culture (static condition) E-cadherin (p = 0.03),
type I collagen (p = 0.04) and amelogenin (p = 0.02) as significant
individual factors positively affecting cell number. For 5 days static
and dynamic conditions, however, no significant results could be
obtained by performing a bulk analysis of the whole data.
Protein-protein interactions have been reported to induce
structural and functional changes in different combinations of pro-
teins [56–58]. The interaction of each protein with different cell
types also dictates the role of each protein. In a particular example,
Heydarkhan-Hagvall et al. [59] reported that scaffolds coated with
vitronectin showed higher cell adhesion rates of embryonic stemFig. 6. Fluorescence microscopy images of BMSCs positive for ALP (in black) on biom
conditions, after (A) 1 day and (B) 5 days of cell culture. Each condition is represented wcells, other than those coated in fibronectin, on a 3D environment.
Moreover, although the integrin-mediated interactions between
cells and ECM proteins as fibronectin, vitronectin and type I colla-
gen are widely reported [60], the specific cell interaction mecha-
nism of amelogenin is still yet not fully understood. A study
made by Kirkham et al. [61], showed that amelogenin interacts
with cells through the cell membrane. Lokappa et al. [62] later
showed that this interaction was made at the membrane phospho-
lipids, and that the N-terminal of amelogenin may be responsible
for this interaction, since enamel malformations of the amelo-
genin’s N-terminal in the disease amelogenesis imperfecta lead to
a faulty interaction between cells and the protein [63]. The improv-
ing effect of amelogenin on the cell number in the scaffolds, both
on static and dynamic culture conditions, may be related to its
adhesive interactions with cells through mechanisms that differ
from other ECM cell-binding proteins. Another possibility to
explain the observed amelogenin’s adjuvant effect relies on the
possible configurational and structural alterations that amelogenin
may induce in other proteins present in the mixtures used to mod-
ify the surface of the chitosan scaffolds.
For ALP detection analysis, pictures of the whole platforms were
acquired using a fixed exposure time, and a bright signal was
detected in the chitosan regions, while on ALP-positive regions a
non-emitting signal could be clearly observed (in black, Fig. 6).
The calculation of ratios between experimental conditions and
the ‘‘control” (protein-free) condition in each independent experi-
ment was calculated in the same way as previously described for
calcein. The ratio values are presented as box plots (median, max-
imum and minimum values) on Fig. S5 (Supporting Information),
and the normalized average mean values are presented in a heat-
map in Fig. 7A, along with the hierarchical clusters (Fig. 7B) of
the results for 1 day of cell culture.
After one day of static cell culture, the conditions that led high-
est and consistent (statistically significant against protein-free
control; p < 0.05) ALP quantifications were FE, VC, FVE and FVEC
(Fig. 7A). None of the proteins alone led to an increase on ALP
quantification. Type-I collagen was highly predominant in mix-
tures leading high ALP production. E-cadherin was also predomi-
nant in the mixtures triggering higher ALP levels. Despite
different mesenchymal cadherins are known to mediate bone for-
mation in vivo [64], the role of E-cadherin has not been disclosedaterial formulations rendering highest ALP signal ratios and control (protein-free)
ith 3 images from independent experiments.
Fig. 7. (A) Heatmap representation of ALP present in all scaffolds cultured under static and dynamic conditions, for 1 day and 5 days of cell culture. The represented values are
normalized (0: minimum to 1: maximum) from the rawmean average values of ALP ratios (normalized by the internal independent experiment control: protein-free scaffold)
based on an automated analysis of image fluorescence. Values obtained for three independent experiments are presented, as well as the calculated mean average (avg; n = 3–
9). Conditions with statistically significantly higher detection of ALP (p < 0.05; t-test against control) are indicated with the ‘‘*” symbol. The respective median and
minimum/maximum values are depicted in Fig. S5 in the Supporting Information. Dentograms with the hierarchical clustering of the average ALP production values for (B)
1 day and (C) 5 days of cell culture for static and dynamic conditions.
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alone, its mixture with ECM adhesive proteins, as fibronectin and
collagen, has led to consistent increasing ALP detection. After
5 days of cell culture under static conditions ALP quantification
levels were, in general, lower than at day 1, as compared to the
protein-free control. The major positive effects on ALP quantifica-
tion were observed in the conditions FV and FVA. For this time-
point, fibronectin clearly has a pronounced effect, as it appears
several times on the conditions leading ALP increased expression.
Tang et al. [65], verified that human plasma fibronectin coated
on scaffold surfaces enhanced odontoblast-like cells proliferation,
differentiation and mineralization. Conditions containing both vit-
ronectin and amelogenin also led increased ALP quantification.
Despite type I collagen has previously shown adjuvant effects on
osteogenic differentiation of MSCs [44], and was mostly effective
on promoting ALP production at day 1, this effect was not observed
at this time point. Different ECM cell-binding proteins have been
proved to act through different pathways. For example, adult mes-
enchymal stem cells grown in 2D substrates treated with adsorbed
vitronectin and type I collagen [44] are driven to osteogenesis
through different mechanisms. Whereas vitronectin correlated
with enhanced focal adhesion formation, the activation of focal
adhesion kinase (FAK) and paxillin, and the diminished activation
of extracellular signal-regulated kinase (ERK) and
phosphatidylinositol-3 kinase (PI3K) pathways, on type-I collagenFig. 8. Calculated effects of a 3-factor model for each protein and protein combinations ithe osteogenic differentiation occurred with lower focal adhesion
formation, reduced activation of FAK and paxillin, and increased
activation of ERK and PI3K. The simultaneous stimulation of differ-
ent pathways in combinatorial biomaterial formulations, along
with 3D culture conditions (in opposition to conventionally used
two-dimensional platforms), may hide the cues to explain the
complex results observed in the studied array.
After one day under flow, the formulations A, VC, FEA, ECA and
FECA led the highest detection of ALP. Here, the effect of
amelogenin alone and in combination with other conditions is
visible and was detected with statistic significant on a multivariate
effect assessment of the mean average values of ALP ratios
(p < 0.03). Conditions that promoted the highest osteogenic
pathway response indicate a possibly positive effect of type-I col-
lagen in coordination with amelogenin under dynamic flow condi-
tions, in opposition to the observations on static culture setup. The
relevance of amelogenin in this process is evidenced by, for exam-
ple, analyzing cell response on EC composition, which rendered
one of the lowest ALP quantification ratios, in opposition to the
high ALP-inducing ECA. The adjuvant and predominant effect of
amelogenin and some of its combinations is also visible after
5 days of cell culture in the bioreactor. The highest ALP quantifica-
tion with low variation was observed for F, V, FV, EA, FVA and FEA
formulations. In a similar way to the observations on static condi-
tions, fibronectin in combination with other proteins shows an ALP production and detected calcein under static and dynamic culture conditions.
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which its presence does not lead to an increase in ALP
quantification.
In summary, after one day of cell culture higher ALP quantifica-
tion seems to be dictated, both on static and dynamic conditions,
by formulations rich in E-cadherin in combination with ECM pro-
teins as fibronectin and vitronectin. On dynamic conditions, the
presence of amelogenin in combination with ECM proteins seems
to drive ALP production by BMSCs. At day 5, the role of fibronectin
is more preponderant, which is probably associated with the abil-
ity of this protein to induce cell adhesion and proliferation when
covalently immobilized in chitosan substrates [66]. After 5 days
of dynamic stimulation, the presence of amelogenin seems to
promote an enhanced pre-osteogenic commitment, indicating a
possible synergic relationship between the protein and the applied
flow.
Surface response analysis is a useful tool to understand the role
of different components on cellular outputs. A three-factor surface
response analysis model enabled the identification of the effect of
individual, binary and ternary combinations of proteins on the
overall BMSCs response to biomaterials. Interesting trends includ-
ing the simultaneous induction of cell attachment and ALP produc-
tion by several proteins could be identified. For example, for static
conditions, at day 1, amelogenin was the main factor driving this
trend (Fig. 8), while under dynamic conditions the presence of
VE, EC and FVC dictated both higher cell number and early ALP
production.
4. Discussion
The technology reported here allowed the affordable and rapid
assessment of protein-BMSCs interactions under static and
dynamic flow perfusion conditions. The system is adaptable to
the application of different flow rates and administration timings
(e.g. discrete or continuous), controlled through a programable
peristaltic pump. The device allowed the application of uniform
flow on all individual miniaturized porous scaffolds.
Each individual component of the bioreactor – i.e., the devel-
oped hollowed platform used to incorporate biomaterials and the
bioreactor chamber – shows versatility and may be adapted to
numerous configurations. Patterned biomaterials may be pro-
cessed with distinct shapes and sizes by modulating the hollows
of the arrayed platform. Additionally, the system may be directed
for the future studies with different cell culture media, variable
flows, multiple cell types (and even co-culture setups), as well as
biomaterials combinations. The versatility and easy modulation
of the bioreactor properties make it an appealing tool to be used
for breakthrough discoveries on healthcare fields, including regen-
erative medicine, drug discovery and disease model/organ-on-a-
chip development.
The flat configuration and precise array position of the 3D scaf-
folds in the developed hollow platforms make them compatible
with the use of automatized robots, commonly used in the prepa-
ration of high-throughput devices. Several perfused chambers con-
taining PDMS perforated arrayed platforms can be assembled in
parallel or in series on commercially available multichannel perfu-
sion pumps. For example, in Fig. 2C two parallel chambers are
assembled in one single peristaltic pump. The parallelizable nature
of this bioreactor allows to: (i) increase time effectiveness of the
experiments, because several independent platforms can be stud-
ied in simultaneous, (ii) study increased numbers of replicates, as
several platforms prepared under the same experimental condi-
tions can be simultaneously assessed using stem cells from con-
trolled batches, and (iii) potentiate the effective high-throughput
versatility of this system, because a virtually unlimited number
of conditions can be simultaneously studied. The diameter andvolume capacity of the syringes used to assemble the bioreactor
chamber may be modulated, enabling the exposure of a different
number of scaffolds to flow perfusion conditions. This versatility
may also be useful to increase the number of studied conditions
per independent experiments, allowing the retrieval of large
amounts of experimental data. On the contrary, the use of minia-
turized biomaterials may be useful to limit the volume of cell cul-
ture medium necessary to perform each experiment, especially in
the case of cell culture media supplemented with costly recombi-
nant molecules (e.g. growth factors).
A literature survey focused on the dynamic stimulation of mes-
enchymal stem cells seeded onto 3D biomaterials with shear stress
values in the range of the ones attained in this study mostly corre-
late dynamic culture conditions with increased cell proliferation
and, inconsistently, both unaltered and increased ALP production
[52]. The exposure of MSCs to low mechanical stimulatory signals
have been correlated with a lower MSCs differentiation into the
adipogenic lineage, and enhanced differentiation into osteoblasts
[67]. The improvement of MSCs osteogenic differentiation by shear
flow, and in particular ALP upregulation, has been correlated with
p38 and ERK activation [68], and also with COX-2 upregulation,
which may regulate the bone morphogenic protein (BMP) pathway
[69,70]. However, the comparison between different studies must
be performed carefully, since several factors rarely coincide
between different literature reports; those include (i) the chemical
and structural nature of the studied biomaterials, (ii) the unifor-
mity of shear stress distribution in the scaffolds, and (iii) the fre-
quency of the application of the flow. This variation leads to
major difficulties in the establishment of reliable comparisons
between bioreactor systems and their respective biological out-
puts. Concerning the role of homogenous distribution of shear
stress onto biomaterials, Egger et al. [54] presented a study where
similar shear stress values were posed to cells, while flow distribu-
tion inside 3D scaffolds served as a main modulator of osteogene-
sis. The average shear stress values calculated for each bioreactor
configuration were in the same order of magnitude: 8 and
9.6 mPa. However, flow distribution inside the trabecular scaffolds’
structures differed between the two setups concerning homogene-
ity, and a more inhomogeneous distribution of the flow on scaf-
folds’ walls was correlated with higher ALP activity and matrix
mineralization [54]. The application of our system enables the
simultaneous flow stimulation of arrays of biomaterials under
the same shear stress conditions, allowing a direct comparison
between studied formulations.
The biomaterial array screened in this study enabled hit-
spotting different proteins as promoters of cell adhesion and ALP
production in BMSCs. The role of protein combinations was also
studied, although analysis must be performed carefully and
restricted to the presence/absence of proteins, without quantity-
based assumptions. The combined effect of cell-matrix and cell-
cell interactions has been recently explored as a potent modulator
of stem cells lineage commitment [41,71]. Previous studies have
focused on the exposure of 3D encapsulated mesenchymal stem
cells to ECM adhesive proteins and soluble growth factors [72].
The characterization of the interplay between stem cells with
integrin-mediated cell-matrix (including full proteins), cell-cell
contact proteins, and other biologically relevant aspects (including
mechanical stimulation [73]) is, however, still poorly described.
Here, two main components – amelogenin and E-cadherin – were
found as enhancers, but no sole players, in the achievement of bio-
material compositions capable of simultaneously increase cell
adhesion and ALP secretion. E-cadherin regulates calcium-
dependent cell-cell adhesion [74], and is present in cells from the
epithelial lineage, such as epithelial stem cells (ESCs) [75].
Nonetheless, for biomaterial-modification purposes E-cadherin
has been suggested as a component of biomaterials capable of
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E-cadherin is involved in cell adhesion, proliferation, migration
and differentiation [77], and its function is reported to go beyond
the establishment of cell-cell junctions; for example, it is known
that it takes part in signaling pathways, including the Rho GTPase
signaling [78,79]. The recurrent presence of amelogenin in hit-
spotted formulations may indicate a correlation between this cell
adhesion protein [80] and mechanotransduction phenomenon
observed in the dynamic conditions assays. Indeed, amelogenin
has been reported as capable of inducing osteogenic differentiation
of embryonic stem cells through the activation of the Wnt
pathway [81].
The interplay between protein composition and dynamic stim-
ulation was shown to modulate cell adhesion and ALP production
in a different manner than in static cell culture. Despite enabling
the retrieval of high amounts of data, the strategy presented here
was applied in a setup common to most high-throughput strate-
gies: biomaterials were tested under shared cell culture medium
– which may lead to crosstalk phenomena -, and data was assessed
only by image analysis. The identified effects and hit-spotted bio-
materials may be used in future approaches as a starting point to
design and validate biomaterials with minimal cues to drive osteo-
genesis. We envision the further use of the developed system on
long-term studies targeting osteogenesis and other tissue regener-
ation setups. The versatility of the method potentiates future tests
using wider arrays of surface-modifying molecules, along with
other cell types, driving new discoveries in the fields of biomateri-
als development for tissue regeneration, drug discovery and
disease models design.5. Conclusion
An arrayed hollow platform was developed to incorporate inde-
pendent 3D miniaturized porous biomaterials that were modified
with 31 different protein formulations present in bone ECM, cell-
cell contact junctions and enamel. The interactions between each
individual biomaterial combination and human BMSCs were tested
on static cell culture conditions, as well as under a dynamic perfu-
sion flow. The results obtained in this study, with 64 conditions
assessed per time point, allowed concluding about the importance
of multiprotein formulations on the triggering of cell adhesion and
osteogenic commitment of BMSCs. Hit-spotted formulations lead-
ing to high cell adhesion and ALP quantification consisted of mix-
tures of ECM-adhesive proteins (namely, fibronectin, type-I
collagen and vitronectin) with cell-cell contact proteins
(E-cadherin) and, with a high consistency, amelogenin. Cell
response and hit-spotted biomaterial formulations were highly
dependent on the application of flow perfusion on the whole sys-
tem. This proof-of-concept work allowed proving the potential of
the developed high-throughput system to test cell-biomaterials
interactions under flow.Acknowledgements
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